Early feedback from patient advocates when designing a clinical trial could mean faster and more successful trials, the US Food and Drug Administration said in a 26 January guidance document.
The document, “Patient Engagement in the Design and Conduct of Medical Device Clinical Studies,” is part of a push...
Welcome to Medtech Insight
Create an account to read this article
Already a subscriber?